Eagan, Minnesota Clinical Trials

A listing of Eagan, Minnesota clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 136 clinical trials
Featured trial
Nuestros Días: Study on the Daily Experiences of Latino/a Family Caregivers

By taking part in this study, participants will help us understand how stressful events impact their well-being as caregivers/care partners of a relative living with memory problems or dementia. Participants will help us identify factors that increase resilience to stress and help us establish the evidence base for culturally responsive, …

Online studies
Accepts healthy volunteers
Online Study Center
(online study) Contact site
  • 38 views
  • 30 May, 2023
  • 1 location
  • Online study
Featured trial
Perception in Parkinson's Disease

The investigators plan to examine the relation of perceptual variables-basic vision, unusual perceptual experiences(including but not limited to visual hallucinations)-to relevant functional variables such as cognition, mood, and alertness/sleepiness in an online sample of persons with Parkinson's disease (PwPD). It is hypothesized that unusual perceptual experiences will relate significantly to …

Online studies
motor symptoms
hallucinations
Vision and Cognition Laboratory, Boston University
(online study) Contact site
  • 11 views
  • 05 Jun, 2023
  • 1 location
  • Online study
Featured trial
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis is a type of bone marrow cancer that usually develops slowly and disrupts body's normal production of blood cells. It causes bone marrow scarring, leading to severe anemia that can cause weakness and fatigue. It can also cause a low number of blood-clotting cells called platelets, which increases …

Minnesota Oncology Hematology, /ID# 227357
 (9.4 away) Contact site
  • 380 views
  • 23 Oct, 2022
  • +149 other locations
A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment With Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Class II Risk Alleles and Have an Inadequate Response to Methotrexate

The purpose of this study is to evaluate the superiority in efficacy of abatacept compared with adalimumab, on background methotrexate, in adults with early, seropositive, and shared epitope-positive rheumatoid arthritis and an inadequate methotrexate response.

cyclic citrullinated peptide antibody
rheumatoid factor
antirheumatics
rheumatism
DMARD
Saint Paul Rheumatology
 (3.0 away) Contact site
  • 0 views
  • 18 Oct, 2022
  • +68 other locations
A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) (VICTORION-2P)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).

Novartis Investigative Site
 (7.8 away) Contact site
  • 1 views
  • 10 Oct, 2022
  • +661 other locations
Veterans Coordinated Community Care (3C) Study (3C)

Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after discharge. Outcomes include suicide-related …

Minneapolis VA Health Care System
 (7.5 away) Contact site
  • 0 views
  • 07 Oct, 2022
  • +4 other locations
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

This is a randomized, double-blinded, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of tildrakizumab compared to placebo in anti-TNF naïve subjects with active PsA .

Sunpharma Site 56
 (3.2 away) Contact site
  • 5 views
  • 06 Apr, 2023
  • +78 other locations
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Fairview Ridges Hospital
 (6.1 away) Contact site
  • 0 views
  • 08 Apr, 2023
  • +595 other locations
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed primary mediastinal B-cell lymphoma (PMBCL). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of cancer cells …

Minnesota Oncology - Burnsville
 (6.1 away) Contact site
  • 61 views
  • 08 Apr, 2023
  • +103 other locations
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in Subjects with Active Psoriatic Arthritis I (INSPIRE 1)

Sunpharma Site no 45
 (3.2 away) Contact site
  • 10 views
  • 10 Apr, 2023
  • +83 other locations